Visual function, optic nerve structure, and ocular blood flow parameters after 1 year of glaucoma treatment ith fixed combinations

Ingrida Januleviciene, Rita Ehrlich, Brent Siesky, Irena Nedzelskiené, Alon Harris

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Purpose. To compare the effects of latanoprost/timolol (LTFC) versus dorzolamide/timolol (DTFC) fixed combinations on intraocular pressure (IOP), visual function, and retrobulbar blood flow in patients with open-angle glaucoma (OAG). Methods. This was a prospective, randomized, double masked, parallel study on 30 patients with OAG. All patients received 4 weeks of timolol treatment prior to randomization to LTFC or DTFC treatment. Measurements after randomization were taken at 1, 6, and 12 months, including arterial blood pressure; IOP; color Doppler imaging of the ophthalmic artery (OA), central retinal artery, and short posterior ciliary artery (SPCA); scanning laser polarimetry; Humphrey visual field examination; and adverse events. Results. IOP decreased by 5.0 mmHg in the DTFC cohort (p<0.000) and 5.44 mmHg in the LTFC cohort (p=0.0001) after 12 months of treatment. No statistically significant differences in visual field or nerve fiber layer thickness were observed between the treatment groups during 12 months of therapy. Mean increase over 1 year of treatment in ocular perfusion and diastolic perfusion pressures were 10.46% and 10.67% in the DTFC group and 7.47% and 5.61% in the LTFC group, respectively. OA resistive index (RI) and SPCA RI were significantly different at the 12 months visit between the two treatment groups (p=0.05 and p=0.000, respectively): DTFC treatment showed decrease in the RI. Conclusions. One year of treatment with LTFC or DTFC resulted in similar IOP lowering effects as well as stable visual function and structure. The DTFC group showed lower vascular resistance in retrobulbar vessels compared to the LTFC group.

Original languageEnglish
Pages (from-to)790-797
Number of pages8
JournalEuropean Journal of Ophthalmology
Volume19
Issue number5
StatePublished - 2009

Fingerprint

Optic Nerve
Glaucoma
Intraocular Pressure
Timolol
Ciliary Arteries
Ophthalmic Artery
Therapeutics
latanoprost
Open Angle Glaucoma
dorzolamide
Random Allocation
Visual Fields
Scanning Laser Polarimetry
Perfusion
Retinal Artery
Nerve Fibers
Double-Blind Method
Vascular Resistance
Arterial Pressure
Color

Keywords

  • Fixed-combination treatment
  • Glaucoma
  • Ocular hemodynamics
  • Optic nerve structure
  • Visual function

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Visual function, optic nerve structure, and ocular blood flow parameters after 1 year of glaucoma treatment ith fixed combinations. / Januleviciene, Ingrida; Ehrlich, Rita; Siesky, Brent; Nedzelskiené, Irena; Harris, Alon.

In: European Journal of Ophthalmology, Vol. 19, No. 5, 2009, p. 790-797.

Research output: Contribution to journalArticle

@article{78647053772f4c798d5ea2c8cb347206,
title = "Visual function, optic nerve structure, and ocular blood flow parameters after 1 year of glaucoma treatment ith fixed combinations",
abstract = "Purpose. To compare the effects of latanoprost/timolol (LTFC) versus dorzolamide/timolol (DTFC) fixed combinations on intraocular pressure (IOP), visual function, and retrobulbar blood flow in patients with open-angle glaucoma (OAG). Methods. This was a prospective, randomized, double masked, parallel study on 30 patients with OAG. All patients received 4 weeks of timolol treatment prior to randomization to LTFC or DTFC treatment. Measurements after randomization were taken at 1, 6, and 12 months, including arterial blood pressure; IOP; color Doppler imaging of the ophthalmic artery (OA), central retinal artery, and short posterior ciliary artery (SPCA); scanning laser polarimetry; Humphrey visual field examination; and adverse events. Results. IOP decreased by 5.0 mmHg in the DTFC cohort (p<0.000) and 5.44 mmHg in the LTFC cohort (p=0.0001) after 12 months of treatment. No statistically significant differences in visual field or nerve fiber layer thickness were observed between the treatment groups during 12 months of therapy. Mean increase over 1 year of treatment in ocular perfusion and diastolic perfusion pressures were 10.46{\%} and 10.67{\%} in the DTFC group and 7.47{\%} and 5.61{\%} in the LTFC group, respectively. OA resistive index (RI) and SPCA RI were significantly different at the 12 months visit between the two treatment groups (p=0.05 and p=0.000, respectively): DTFC treatment showed decrease in the RI. Conclusions. One year of treatment with LTFC or DTFC resulted in similar IOP lowering effects as well as stable visual function and structure. The DTFC group showed lower vascular resistance in retrobulbar vessels compared to the LTFC group.",
keywords = "Fixed-combination treatment, Glaucoma, Ocular hemodynamics, Optic nerve structure, Visual function",
author = "Ingrida Januleviciene and Rita Ehrlich and Brent Siesky and Irena Nedzelskien{\'e} and Alon Harris",
year = "2009",
language = "English",
volume = "19",
pages = "790--797",
journal = "European Journal of Ophthalmology",
issn = "1120-6721",
publisher = "Wichtig Publishing",
number = "5",

}

TY - JOUR

T1 - Visual function, optic nerve structure, and ocular blood flow parameters after 1 year of glaucoma treatment ith fixed combinations

AU - Januleviciene, Ingrida

AU - Ehrlich, Rita

AU - Siesky, Brent

AU - Nedzelskiené, Irena

AU - Harris, Alon

PY - 2009

Y1 - 2009

N2 - Purpose. To compare the effects of latanoprost/timolol (LTFC) versus dorzolamide/timolol (DTFC) fixed combinations on intraocular pressure (IOP), visual function, and retrobulbar blood flow in patients with open-angle glaucoma (OAG). Methods. This was a prospective, randomized, double masked, parallel study on 30 patients with OAG. All patients received 4 weeks of timolol treatment prior to randomization to LTFC or DTFC treatment. Measurements after randomization were taken at 1, 6, and 12 months, including arterial blood pressure; IOP; color Doppler imaging of the ophthalmic artery (OA), central retinal artery, and short posterior ciliary artery (SPCA); scanning laser polarimetry; Humphrey visual field examination; and adverse events. Results. IOP decreased by 5.0 mmHg in the DTFC cohort (p<0.000) and 5.44 mmHg in the LTFC cohort (p=0.0001) after 12 months of treatment. No statistically significant differences in visual field or nerve fiber layer thickness were observed between the treatment groups during 12 months of therapy. Mean increase over 1 year of treatment in ocular perfusion and diastolic perfusion pressures were 10.46% and 10.67% in the DTFC group and 7.47% and 5.61% in the LTFC group, respectively. OA resistive index (RI) and SPCA RI were significantly different at the 12 months visit between the two treatment groups (p=0.05 and p=0.000, respectively): DTFC treatment showed decrease in the RI. Conclusions. One year of treatment with LTFC or DTFC resulted in similar IOP lowering effects as well as stable visual function and structure. The DTFC group showed lower vascular resistance in retrobulbar vessels compared to the LTFC group.

AB - Purpose. To compare the effects of latanoprost/timolol (LTFC) versus dorzolamide/timolol (DTFC) fixed combinations on intraocular pressure (IOP), visual function, and retrobulbar blood flow in patients with open-angle glaucoma (OAG). Methods. This was a prospective, randomized, double masked, parallel study on 30 patients with OAG. All patients received 4 weeks of timolol treatment prior to randomization to LTFC or DTFC treatment. Measurements after randomization were taken at 1, 6, and 12 months, including arterial blood pressure; IOP; color Doppler imaging of the ophthalmic artery (OA), central retinal artery, and short posterior ciliary artery (SPCA); scanning laser polarimetry; Humphrey visual field examination; and adverse events. Results. IOP decreased by 5.0 mmHg in the DTFC cohort (p<0.000) and 5.44 mmHg in the LTFC cohort (p=0.0001) after 12 months of treatment. No statistically significant differences in visual field or nerve fiber layer thickness were observed between the treatment groups during 12 months of therapy. Mean increase over 1 year of treatment in ocular perfusion and diastolic perfusion pressures were 10.46% and 10.67% in the DTFC group and 7.47% and 5.61% in the LTFC group, respectively. OA resistive index (RI) and SPCA RI were significantly different at the 12 months visit between the two treatment groups (p=0.05 and p=0.000, respectively): DTFC treatment showed decrease in the RI. Conclusions. One year of treatment with LTFC or DTFC resulted in similar IOP lowering effects as well as stable visual function and structure. The DTFC group showed lower vascular resistance in retrobulbar vessels compared to the LTFC group.

KW - Fixed-combination treatment

KW - Glaucoma

KW - Ocular hemodynamics

KW - Optic nerve structure

KW - Visual function

UR - http://www.scopus.com/inward/record.url?scp=70549109863&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70549109863&partnerID=8YFLogxK

M3 - Article

VL - 19

SP - 790

EP - 797

JO - European Journal of Ophthalmology

JF - European Journal of Ophthalmology

SN - 1120-6721

IS - 5

ER -